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ABSTRACT
Precise regulation of gene expression is crucial to
myogenesis and is thought to require the cooper-
ation of various transcription factors. On the
basis of a bioinformatic analysis of gene regulatory
sequences, we hypothesized that myogenic regu-
latory factors (MRFs), key regulators of skeletal
myogenesis, cooperate with members of the SIX
family of transcription factors, known to play
important roles during embryonic skeletal
myogenesis. To this day little is known regarding
the exact molecular mechanism by which SIX
factors regulate muscle development. We have con-
ducted a functional genomic study of the role played
by SIX1 and SIX4 during the differentiation of
skeletal myoblasts, a model of adult muscle regen-
eration. We report that SIX factors cooperate with
the members of the MRF family to activate gene ex-
pression during myogenic differentiation, and that
their function is essential to this process. Our
findings also support a model where SIX factors
function not only ‘upstream’ of the MRFs during em-
bryogenesis, but also ‘in parallel’ to them during
myoblast differentiation. We have identified new es-
sential nodes that depend on SIX factor function, in
the myogenesis regulatory network, and have un-
covered a novel way by which MRF function is
modulated during differentiation.
BACKGROUND
Skeletal muscle development is a complex process
regulated in large part by sequence-speciﬁc transcription
factors (TFs). They govern the ordered expression of a
multitude of genes along the successive steps of
myogenesis, from the engagement of mesodermal cells in
the muscle lineage, to the differentiation of somitic cells,
to the terminal differentiation of myocytes into myoﬁbers
[reviewed in refs. (1–3)].
In terms of gene regulation, the differentiation of
muscle is a system where complexity manifests itself
both in the precise location and timing of gene expression
patterns. Accurate gene transcription is made possible in
part by the convergence of regulatory inputs from differ-
ent TFs on single genes. For example, during fruit ﬂy larva
mesoderm development, several factors converge to drive
in a combinatorial fashion the expression of genes to
speciﬁc mesodermal compartments and during precise
time periods (4).
In vertebrates, the making of muscle is coordinated in
part by the action of TFs of the myogenic regulatory
factor family (MRFs), which counts four members:
MYOD, MYF5, MYOG (myogenin) and MRF4 (5).
These basic helix–loop–helix TFs bind DNA as dimers
with E-proteins to a DNA sequence element termed the
E-box (consensus CANNTG). MRFs function in a
cascade fashion and may regulate each other’s expression.
For example, MYOD regulates the expression of Myog,
and MYOG can activate the expression of Mrf4 (6). At
the same time, both MYOD and MYOG have the ability
to enhance their own expression (7).
It is clear that the function of the MRFs in regulating
target gene expression is coupled to that of other TFs.
Logically, it is difﬁcult to envision a regulatory scheme
by which these four TFs could establish by themselves
the complex gene expression proﬁles that pattern muscle.
For instance, Molkentin et al. (8) have shown that tran-
scriptional activation by the MRFs is enhanced by the
function of MEF2 TFs. However, as key regulators,
MRFs’ cooperation with other TFs in regulating precise
gene expression in myogenesis deserves to be further
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identity of a large number of direct transcriptional targets
of the MRFs (9–11). We have demonstrated that certain
TF binding sites are speciﬁcally enriched among the regu-
latory regions of this large set of MRF targets, suggesting
the identity of partners in combinatorial regulation. The
A/T rich element recognized by MEF2 was among those
discovered, and indeed we and others have conﬁrmed
the recruitment of MEF2 to several of these sites.
Nevertheless, cooperation of MRFs and their co-factors
is far from being fully understood, and cooperation of
MRFs with not one but a variety of TFs, for example at
different time points or on different target gene promoters,
is likely to occur.
Another motif we discovered as speciﬁcally enriched
among MRF target promoters was the MEF3 element
(consensus TCAGGTTTC) (9). The MEF3 sequence was
found to be most abundant for MRF target genes whose
expression is signiﬁcantly induced during differentiation.
This sequence element is known to be recognized by TFs
of the SIX family, which led us to hypothesize that MRF
function during myogenic differentiation is modulated by
combinatorial regulation with the SIX factors.
The SIX proteins belong to a family of six
homeodomain TFs, from SIX1 to SIX6, which are
involved in controlling the development of a number of
tissue types [reviewed in refs. (12,13)]. Importantly, the
functions of SIX1 and SIX4 are tied to skeletal muscle
development: Six1-null mice die at birth from respiratory
failure, with grave defects in trunk musculature due in part
to impaired primary myogenesis (14–16). While Six4-null
mice appear normal (17), compound mutant Six1;Six4-
null mice display a more pronounced impairment in
myogenesis than Six1-null animals (18). Because loss of
Six1 leads to perinatal lethality, comparatively less atten-
tion has been given to the role it plays after birth, in adult
muscle and during muscle repair. It is known however that
in addition to their role in the early phase of muscle de-
velopment, SIX1 has an inﬂuence on establishing muscle
ﬁber type: enhancing the activity of SIX1 leads to an
increase in the number of fast-twitch (glycolytic) muscle
ﬁbers, and to higher expression of genes stereotypical of
this class of myoﬁbers (19). Expression proﬁling data from
embryonic tissue of Six1;Six4 double knock-out embry-
onic tissue also support the notion that SIX factors are
required to activate in the myotome the expression of
fast-type muscle genes (20). In line with this, in zebraﬁsh,
loss of function of the six1a gene causes abnormal
fast-twitch muscle formation (21). Taken together, these
data indicate that SIX1 and SIX4 are critical for embry-
onic muscle development.
Despite its clear role in regulating the formation of
muscle, and other tissues, few genes have been shown to
be under the direct transcriptional control of SIX1 during
myogenesis. Over-expression approaches followed by gene
expression proﬁling have been used, leading to the identi-
ﬁcation of potential SIX1 and SIX4 target genes (22). On
the basis of their deregulation in Six1 knock-out animals,
a number of targets have been identiﬁed or are thought to
represent direct targets (16,18). Importantly, among direct
SIX1 target genes are two MRFs, Myog and Myf5 (23,24).
The expression levels of Pax3, Myod1, MRF4 and Lbx1,
all encoding TFs playing critical roles in embryonic
myogenesis, have also been shown to be affected by the
loss of Six1, but it is unknown in these cases if the regu-
lation is direct or mediated by the product of one or more
genes regulated by SIX1. Considering the essential roles of
MRFs and SIX factors for muscle differentiation, we hy-
pothesize that MRFs and SIX factors function in a com-
binatorial manner.
In order to verify our hypothesis that MRFs may co-
operate with SIX factors during myogenesis, we have used
a combination of genomic approaches to analyze SIX1
AND SIX4 function during myoblast differentiation. We
found that as predicted by our bioinformatic analyses,
MRFs’ function is potentiated by SIX factors. These
two families of TFs together play a pervasive role in es-
tablishing the proper gene expression proﬁles that enable
differentiation of muscle precursor cells, by directly
regulating the expression of genes that control not only
the development of muscle but also its function once ter-
minally differentiated.
MATERIALS AND METHODS
Cell culture and RNA interference
C2C12 myoblasts were acquired from the American Type
Culture Collection and cultured as described earlier (9).
For all ChIP-on-chip and expression proﬁling experiments
performed on differentiated myotubes (MT), the cells were
separated from undifferentiated ‘reserve’ cells using differ-
ential trypsinization (25). Human embryonic kidney car-
cinoma cells HEK293T cells were obtained from the
ATCC and grown in DMEM supplemented with 10%
fetal bovine serum, glutamine and antibiotics. For RNA
interference experiments, C2C12 cells were seeded at
100000 cells in 6-well plates (Corning) and were trans-
fected with siRNA (Dharmacon) using Lipofectamine
2000 and the recommended lipofection protocol
(Invitrogen). siRNA oligo sequences are given in
Supplementary Table S6.
Antibodies
Recombinant mouse SIX1 (full-length protein) or mouse
SIX4 (amino acids 414–775) fused to N-terminal
hexa-histidine tags and puriﬁed from Escherichia coli on
Ni–NTA beads (GE Healthcare) were used to immunize
rabbits (Open Biosystems). Rabbit sera were puriﬁed by
afﬁnity to the cognate recombinant proteins, puriﬁed from
E. coli as N-terminal glutathione-S-transferase fusion
proteins on glutathione agarose (Pierce Chemicals).
Western blots on C2C12 whole lysates using anti-SIX1
or anti-SIX4 each revealed only one band, and chromatin
immuno-precipitations followed by immuno-blotting con-
ﬁrmed antibody speciﬁcity (data not shown, and
Supplementary Figure S6). Other antibodies used
include anti-myosin heavy chain (MHC, MF20 clone,
obtained from the Developmental Studies hybridoma
Bank, DSHB), anti-myogenin (clone F5D, DSHB,
contributed by W. Wright), anti-b-tubulin (clone E7,
DSHB). Secondary antibodies against mouse or rabbit
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Chemicals), were used in western blotting experiments.
The secondary antibody used in immuno-ﬂuorescence ex-
periments is anti-mouse coupled to FITC (Jackson
Immunoresearch).
ChIP assays and ChIP-on-chip
Chromatin immunoprecipitations were performed as
described in ref. (9), using 2mg of antibody and 25mgo f
chromatin DNA. Normal rabbit IgG (Pierce Chemicals)
was used as a negative control antibody. After clean-up,
the immunoprecipitated DNA was quantitated using
qPCR employing the SYBR green chemistry on a
MX3005p instrument (Stratagene). Each sample was
used in duplicate PCR reactions. For each time point
and each biological replicate, an aliquot of the ‘input’
starting chromatin material was used to create a dilution
curve in order to express target DNA abundance in the IP
samples as a percentage of that in the starting material
(percent of input values). The Hoxd10 promoter was
used as a negative control locus, with no recruitment of
the TFs being studied. See Supplementary Table S6 for a
list of primers used in ChIP assays. A stringent
multi-criteria method was used to evaluate factor
binding by qChIP. To be considered a true binding
event, each IP sample had to pass three tests: giving
higher enrichment than with the control antibody (at the
same time point and same locus, one-tailed t-test paired
with P<0.05), higher enrichment than at the HoxD10
locus (at the same time point and with same antibody,
one-tailed t-test unpaired with P<0.05), and average en-
richment levels at least 10 times higher than with the
control antibody. Details of ChIP-on-chip experiments
and microarray design are provided in Supplementary
Methods. The normalized ChIP-on-chip dataset has
been deposited in the GEO database, under accession
number GSE20150.
Quantitative reverse-transcription PCR
Total RNA was isolated from cells using the Absolutely
RNA Miniprep Kit (Stratagene) following the manufac-
turer protocol including DNase I treatment. RT–PCR was
performed using the SuperScript

First-Strand Synthesis
System for RT–PCR (Invitrogen) using random hexamers
to initiate the reaction. qRT–PCR was performed with the
MX3000P platform (Stratagene) using the Syber Green
quantiﬁcation method and ROX normalization. Relative
quantiﬁcation was performed using the efﬁciency-
corrected method. Genes were normalized using the
Rps26 gene.
Gene expression proﬁling
For the time course of C2C12 differentiation, cells were
handled as described in ref. (9). For proﬁling following
RNAi, cells were transfected subconﬂuent in growth
medium. The next day, differentiation was induced. Cells
were harvested one day later. Expression proﬁling was
done using the One-Color Microarray Gene Expression
Platform and the 4x44k Whole Mouse Genome Oligo
microarray (Design ID #014868) from Agilent
Technologies. Details are given in Supplementary
Methods. Microarray data can be downloaded from the
Gene Expression Omnibus, under accession number
GSE19988.
Gene expression data from the mouse GeneAtlas V3
[GNF3, (26)] were downloaded from GEO (GSE10246)
and analyzed using the dChip program, with quantiles
normalization (27). Genes were further normalized to a
median of 0 and a SD of 1, across all tissues. Affymetrix
microarray probes were matched to target genes or to
Agilent expression proﬁling probes using matching
GeneID numbers.
k-means clustering of expression proﬁling microarray
data was performed with the Cluster 3 program using
Euclidean metrics, and visualized using Java Treeview
(28,29). When performed on the differentiation
time-course experiments, clustering was done on all
probes on the expression microarray and genes were
assigned to one of ﬁve clusters. After clustering, only
SIX1-bound genes were retained.
Immuno-ﬂuorescence
C2C12 myoblasts were grown in slide ﬂasks (Nunc) and
transfected with siRNA when they reached a conﬂuence of
75–80%. Differentiation was induced the next day, and
the cells were transfected again with the same siRNA mol-
ecules 24h later to maintain the knock-down of target
genes. The cells were ﬁxed at 72h after start of differenti-
ation, and processed for immuno-ﬂuorescent detection as
described in ref. (30). Images were taken on a Leica
DMI6000 B immuno-ﬂuorescence microscope at a magni-
ﬁcation of 10. Images were acquired with the Velocity
software version 5.0.2 (Improvision). Ten random ﬁelds
were taken on each slide. The TIFF images from each
color channel were merged and intensity adjusted using
the Levels tool in Adobe Photoshop version 13.0.
Fusion and differentiation indices were calculated; they
are, respectively, deﬁned as the fraction of MT with at
least three nuclei over the total number of nuclei, and
the fraction of nuclei within MHC-positive cytoplasms
over the total number of nuclei.
Reporter constructs
All luciferase reporter constructs used in this study were
made in the pGL3-Basic backbone (Promega). The
pGL3-TATA-Luc construct, containing the TATA box
from the adenoviral E1B gene, has been described before
(31). The 6xMEF3-TATA-Luc construct was made by an-
nealing complementary oligos (sequence given in
Supplementary Table S6) containing the MEF3 site from
the myogenin promoter (TCAGGTTTC), which were then
ligated together to form concatamers and cloned into
pGL3-TATA-Luc. The 4xEbox-TATA-Luc was con-
structed by excising the four E-box copy insert from
4R-tk-luc construct (32) and cloning into pGL3-
TATA-Luc. The 5xE2F-TATA-Luc construct contains
ﬁve copies of the E2F binding site sequence upstream of
the E1B TATA box and has been described before (31).
Constructs containing various combination of these
TF binding sites were made using similar strategies.
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ﬁcation from C2C12 genomic DNA. A mutation in the
MEF3 site was incorporated by changing the sequence
of this element from GGGCTCAGGTTTCTGT to
GGGgagagagagaTGT.
Expression plasmids
The mouse SIX1 coding sequence cloned into the
p3xFlag-myc plasmid (Sigma) was a kind gift from G.
Merlino (33). The mouse SIX4, MYOD, MYOG and
Heb-beta coding sequences were ampliﬁed from cDNA
prepared from C2C12 total RNA and cloned into
p3xFlag-myc. The human E2F1 and DP1 expression
plasmids, with a pcDNA3 backbone, have been described
previously (31).
Promoter reporter assays
Cells (C2C12 or 293T) were seeded in 24-well tissue
culture plates, and transfected the following day with
1mg of DNA using TurboFect (MBI Fermentas) accord-
ing to the manufacturer’s protocol. The amount of DNA
typically included 250ng of reporter DNA and 5ng of
pRL-CMV (Promega), expressing renilla luciferase under
the control of the CMV promoter. The cells were har-
vested 24 hours after transfection by washing in
phosphate-buffered saline (PBS) and lysing in passive
lysis buffer (Promega). Fireﬂy and renilla luciferase
activities were then assayed using the Dual-luciferase
assay system (Promega) on a GloMax luminometer
(Promega), and ﬁreﬂy enzymatic activities were divided
by those of the renilla enzyme. Data were normalized by
the intensities obtained with the empty, pGL3-Basic
plasmid, or by those obtained with an empty expression
plasmid. We quantiﬁed transcriptional synergy as the ratio
of the transcriptional activation obtained with two TFs
over the sum of activations obtained with each factor
alone, as reported in ref. (34). In experiments where dif-
ferentiation of C2C12 myoblasts was induced, the cells
were transfected at the myoblast stage, and harvested
either one day later, in their undifferentiated,
sub-conﬂuent state in growth medium, or allowed to
grow to conﬂuence, switched to differentiation medium,
and harvested 4 days later. In these experiments, renilla
activity drops several folds during the time course of dif-
ferentiation and becomes an unreliable internal control.
To circumvent this problem, ﬁreﬂy luciferase activity
values were instead normalized by the total protein con-
centrations of the lysates, measured using the
bicinchoninic acid protein assay (BCA, Pierce Chemicals).
RESULTS
Genome-wide binding proﬁle of SIX1
In order to study the role of SIX factors in relation with
the MRFs, we used the well characterized C2C12 mouse
myoblast cell line, which represents a model of activated
satellite cells undergoing terminal differentiation. Western
blot on lysates of C2C12 cells at different time points of
the differentiation program indicates that SIX1 is
expressed in this myogenesis model system (Figure 1A).
It is expressed in myoblasts, its levels increase at the onset
of differentiation, and then decline in differentiated MT.
In comparison, the expression of myogenin occurs after
24h of differentiation (T24h) and is maintained in MT.
We next wanted to verify that SIX1 is functional in
C2C12 cells. For this, chromatin immuno-precipitation
assays followed by qRT–PCR (qChIP) were performed
to detect binding of Six1 on the myogenin proximal
promoter, a known target of SIX factors during embryo-
genesis (23). We could detect a speciﬁc binding of SIX1 at
this promoter, but not at the negative control locus, the
promoter of the HOXD10 gene, which is not expressed in
C2C12 cells (Figure1B). Interestingly, the proﬁle of
binding of SIX1 changes over time, during differentiation:
while we detected signiﬁcant recruitment of SIX1 in both
myoblasts and MT, it is in MT that we detected the
strongest binding signal of SIX1 to the myogenin
promoter. MYOG binding to its own promoter is only
reliably detected in differentiated cells, as expected.
The phenotype of Six1-null mouse embryos suggests a
substantial deregulation of the myogenic gene expression
program in these animals, since several genes are affected
by SIX1 loss. Further, our bioinformatic analyses suggest
a widespread role for SIX1 in myogenesis. We reasoned
that SIX1 must play a global, genome-wide role in
controlling the differentiation of myoblasts into MT,
and therefore decided to perform ChIP-on-chip analyses
to determine the genomic binding proﬁle of SIX1 in
C2C12 cells. Because SIX1 expression is modulated
during this process (Figure 1A) and SIX1 can be recruited
on Myog promoter region (Figure1B), we performed
ChIP-on-chip at three different time points: in
proliferating myoblasts, in myoblasts after 24h of differ-
entiation induction (T24h) and in fully differentiated MT.
We used oligonucleotide tiling DNA microarrays contain-
ing a total of 2.9-million probes representing 17% of the
mouse genome, at an average density of more than ﬁve
probes per kilobase (kb) (see Supplementary Material and
methods for details).
We identiﬁed with high conﬁdence 1019 binding sites of
SIX1 in myoblasts, 739 at T24h, and 1852 in MT, for a
total of 2624 individual genomic binding sites (Figure 1C
and Supplementary Table S1). Representative genomic
binding proﬁles are shown in Supplementary Figure S2.
We used a multi-factorial algorithm to assign target genes
to these binding events (‘Materials and Methods’ section),
allowing us to determine that SIX1 targets 750 genes in
myoblasts, 568 genes at T24, and 1313 genes in MT, for a
total of 1793 genes. This reduction from number of
binding sites to number of genes is explained in part by
the facts that in certain instances SIX1 binds at more than
one site near or within a gene, and conversely that some
binding events are extremely far from any known
transcribed region. Interestingly, the genome binding
proﬁle of SIX1 appears to be modulated during
myogenesis, as this protein binds only partially
overlapping sets of target loci at the three time points
investigated. Despite being the least abundant in MT, it
is in these differentiated cells that Six1 appeared to bind
the largest number of loci. We stress however that due to
6860 Nucleic Acids Research, 2010,Vol.38, No. 20the stringent cut-off we established in data analysis, a
number of loci appearing as ‘condition-speciﬁc’ may in
fact be bound by SIX1 at more than one time point (we
privileged a low rate of false positives at the expense of
reporting more false negatives). Figure 1D represents
validatory qChIP on selected targets. Additional qChIP
conﬁrmatory data are shown in Supplementary Table
S2. For these validations, we also used an antibody
directed against SIX4, since it is expressed in C2C12
cells just like SIX1 and it is expected to bind a DNA
sequence similar to that of SIX1(23,24). Interestingly, we
found that SIX4 binding was indeed detected to most
SIX1 target loci we tested, suggesting that SIX1 and
SIX4 are recruited to similar loci in muscle cells, and
that perhaps both factors operate together.
SIX1 binds to genes belonging to several functional
categories
We used the gene ontology classiﬁcation (35) to identify
biological processes that would be over-represented
among the SIX1-bound genes (Table 1). Genes
participating in developmental processes are the most
abundant and represent the most highly enriched func-
tional category among SIX1 targets. Not surprisingly,
the category of muscle development is a process whose
abundance is well above random expectations. For
example, and as expected, our genome-wide analysis
identiﬁed the myogenin locus as bound by SIX1.
Characterization of the role of SIX1 in regulating this
category of target genes is currently ongoing and will be
reported later. Interestingly, genes participating in
neuronal development also constitute a large fraction of
genes bound by SIX1. This may explain the appearance of
a cluster of SIX1 target genes with predominant expres-
sion in nervous system tissues (Supplementary Figure S1).
An interesting observation we made is that SIX factors
engage in auto-regulation within their family: we
detected binding of SIX1 to the Six1, Six4 and Six5 regu-
latory regions (Supplementary Table S2). This has import-
ant implications as it represents a putative mechanism for
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Figure 1. SIX1 is functional in C2C12 myoblasts. (A) Western blot quantitation of SIX1 expression in differentiating C2C12 cells. Total cell lysates
were used, and membranes were probed for SIX1 and myogenin expression. T0h, conﬂuent myoblasts at the onset of differentiation induction.
T24h, myoblasts induced to differentiate for 24h. Beta-tubulin is given as a loading control. (B) Binding of SIX1 to the endogenous myogenin
promoter, measured by qChIP. The chromatin from C2C12 cells at different stages of differentiation was immunoprecipitated with antibodies against
SIX1 or MYOG, or control rabbit IgG. Enrichment of the ChIP samples for the myogenin promoter sequence and a negative control region
(Hoxd10), were measured by qPCR. The binding signal expressed as a proportion of the starting material recovered in the ChIP reaction (percent of
input). Asterisks indicate that the enrichment passes three signiﬁcance tests, as indicated in ‘Materials and Methods’ section. The data represent the
average of at least three biological replicates. Error bars: standard error on the mean (SEM). (C) Venn diagram showing the overlap in regions
bound by SIX1 in myoblasts, at 24h of differentiation, and in MT. The numbers given are the number of bound regions, and those in parentheses
represent the number of distinct genes bound. (D) Validation of SIX1 ChIP-on-chip ﬁndings using qChIP. ChIP and data analysis were performed as
described in Figure 1B. Average of at least three biological replicates. Error bars: SEM. Asterisks indicates signiﬁcant binding event, as in B.
Nucleic Acids Research, 2010,Vol.38, No. 20 6861functional compensation, which is hypothesized to occur
in the Six1 or Six4 knock-out mice (14,17,18,36). The
Eya4 gene is also targeted by SIX1, suggesting a further
layer of auto-regulation, since this protein functions as
transcriptional co-regulator of SIX factor function, and
interacts directly with SIX1 (37).
Interestingly, the function of SIX1 is not limited to the
regulation of genes that enable the early developmental
phases of myogenesis: we note that several genes
encoding components of the contractile apparatus are
also targeted by SIX1, such as titin, various troponin
(Tnni1, Tnni2, Tnni3) and myosin (Myh7, Myh13, Myl1,
Myl4) isoforms and ATP-dependent sodium–potassium
channels (Atp1a1, Atp1a2, Atp2a1). These genes tend to
have an expression pattern highest in muscle tissues, as
compared to other adult mouse tissues (Supplementary
Figure S1 and Table S3). We note that genes characteristic
of both fast and slow muscle ﬁber types are bound by
SIX1, for example Tnnc1, Tnni1 and Tnnt1 (slow) and
Atp2a1, Tnni2 and Tnnt3 (fast).
Coordinate genomic binding of SIX factors and the MRFs
DNA sequence analysis of the genomic regions bound by
SIX1 revealed that the E-box element, recognized by
MYOD and MYOG, is signiﬁcantly enriched among
these sequences, as compared to randomly selected se-
quences surveyed in our ChIP-on-chip experiments (data
not shown). Cao et al. (11) recently published the global
mapping of MYOD binding sites using ChIP-seq in
C2C12 cells. Strikingly, we found that, regardless of the
condition, 39% of SIX1-bound loci identiﬁed herein
overlap with the MYOD-bound regions reported by Cao
et al. (400 out of 1021 in myoblasts, and 741 out of 1853 in
MT, with overlap of at least 1bp) This signiﬁcant overlap
(P<110
15 by hypergeometric distribution test)
strongly suggests a concerted mode of action of SIX
factors and the MRFs.
SIX1 and SIX4 are required for myoblast differentiation
Considering our ﬁnding that SIX factors bind to a large
number of genes playing important roles in myogenesis,
we used short interfering RNA duplexes (siRNAs) to
knock-down their expression from myoblasts, in order
to determine if SIX1 and SIX4 functions are required
for myoblast differentiation. We transfected C2C12
myoblasts with siRNAs targeting either the Six1
mRNA, the Six4 mRNA, both together or a control
non-targeting RNA duplex. One day later, the cells were
induced to differentiate and were harvested after 2 or 4
days in differentiation medium, for immuno-blotting or
for immuno-ﬂuorescent scoring of their differentiation,
respectively. Western blots (Figure 2A) indicate that the
knock-downs of SIX1 and SIX4 were substantial.
Interestingly, the expression of myogenin was markedly
decreased after knock-down of either Six factor, an
effect in line with the role of SIX factors on MYOG in-
duction during embryonic myogenesis. The cells were
stained for their expression of myosin heavy-chain
(MHC), a terminal myogenic differentiation marker, and
their DNA was counterstained with DAPI, allowing us to
measure their differentiation and fusion indices (Figure 2B
and C). We found a remarkable statistically signiﬁcant
impairment of both myoblast differentiation and fusion
when either SIX factors were knocked-down, indicating
that these factors are essential not only for induction of
myogenin expression, but also for the proper course of
differentiation. Similar effects were obtained when
knock-down was performed for SIX1 or SIX4 using
pools of three siRNA duplexes (Supplementary
Figure S3) which exclude the sequences used in Figure 2,
making it unlikely that the failure to differentiate
caused by knock-down of SIX proteins is due to off-target
effects. Together, these results show that SIX1 and SIX4
are functional in C2C12 cells and that they are likely
to directly regulate the induction of myogenin
expression. Our results also indicate that because they
are required for myoblast differentiation, SIX factors
function extend beyond the early phase of embryonic
muscle development.
A pervasive role for SIX proteins: activating gene
expression during myogenesis
The genome-wide binding proﬁle of SIX1 suggests that
several genes important for muscle formation and
activity are directly regulated by SIX factors. In order to
establish a correlation between gene regulation and SIX
Table 1. Selected gene ontology biological processes signiﬁcantly enriched among genes targeted by SIX1
Category Targets: total (Mb; T24h; Mt) P-value
a Example gene products
System development 260 (124; 91; 183) 2.40E-15 PBX1, MEIS2, FOXA2, GSK3B, HOXC6, INHBB
Nervous system development 99 (48; 35; 68) 1.70E-04 NEUROD6, GDNF, DPYSL2, FGF5, HES6, NRXN3
Reg. of transcription from RNA
pol. II promoter
86 (39; 33; 65) 5.51E-07 HDAC4, ARNTL, E2F6, ELF1, KLF13, MEIS1
Muscle development 58 (21; 20; 48) 7.35E-15 MYF5, MYOD1, MYOG, VGLL2, MEF2C, PITX2
Cell motility 65 (30; 23; 48) 3.14E-04 ITGA6, ITGB3, STMN1, MTSS1, DCC, TNS1
Regulation of cell proliferation 60 (28; 25; 41) 2.01E-03 CDKN1A, E2F7, GAS1, KIFAP3, MYC, RB1
Vasculature development 56 (26; 20; 38) 4.05E-06 ADAMTS1, ANGPT1, ANXA2, CYR61, EMCN, PDGFA
Heart development 41 (15; 15; 27) 1.09E-05 ACVR1, PITX2, NFATC4, BMP4, CSRP3, MEF2C
Muscle contraction 33 (10; 7; 30) 9.66E-10 TTN, TNNI3, RYR1, MYH7, TPM3, ACTN3
Kidney development 17 (10; 7; 12) 1.48E-02 GLI2, BDNF, GZF1, NPNT, GREM1, SPRY1
aThe P-values given are using Fisher’s exact test, with correction for multiple hypothesis testing by the algorithm of Benjamini and Hochberg.
The background set of genes used in these calculations was the entire mouse genome.
6862 Nucleic Acids Research, 2010,Vol.38, No. 20function, we performed expression proﬁling of C2C12
cells undergoing differentiation (Supplementary Table
S4). Figure 3A represents as a heat-map the expression
proﬁles of direct SIX1 targets as myoblasts differentiate
into MT, clustered by a k-means algorithm. We note that
SIX1 target genes have a variety of expression proﬁles
during differentiation, with substantial numbers falling
into each of ﬁve clusters, including genes with no detect-
able expression in C2C12 cells (cluster #5). Interestingly
however, a large proportion of target genes are either
highly or moderately induced, during differentiation
(clusters #1 and #2). This analysis reveals that
binding by SIX1 in MT is strongly associated to target
gene activation: for example, of the 21 493 genes
proﬁled using our expression microarrays, 446 fall
into cluster #1 (highly induced), and 141 of those are
bound by SIX1 in MT. The chance for this association
to occur randomly is exceedingly small (P<10
20 for
the cumulative hypergeometric probability). Since this
analysis shows that nearly one-third of the most induced
genes during myoblast differentiation are targeted by
SIX1, we conclude that this factor must play a very im-
portant role in activating gene expression during
myogenesis.
In order to establish a more direct link between the role
of SIX proteins and gene activation during differentiation,
and to verify whether the function of these proteins is
required for the efﬁciency of myogenesis, we examined
the effects of loss of SIX expression caused by RNA inter-
ference. As for Figure 2A, we transfected C2C12
myoblasts targeting either the SIX1, SIX4 or both, or a
control non-targeting RNA duplex, and induced the cells
to differentiate one day later. For comparison, we also
used an siRNA duplex against myogenin. The cells were
allowed to differentiate for one day, after which we har-
vested their RNA and performed gene expression
proﬁling. This early time point was chosen to minimize
secondary effects, which may plague this sort of assay.
Western blots and quantitative reverse-transcription
PCR (qRT–PCR) indicate that substantial knock-downs
were achieved (Figure 3B–D). Here again, the knock-
down of either SIX1 or SIX4 led to a signiﬁcant
decrease in the levels of MYOG protein and mRNA. By
microarray expression proﬁling, we found 380 genes to be
down-regulated by more than 50% after SIX1 loss of
function; among those, 165 are direct targets as they are
bound by SIX1 (Supplementary Table S5 and
Supplementary Figure S3). We lined up the expression
proﬁles of these deregulated SIX1 targets with their
normal proﬁles during differentiation (Figure 3E).
Strikingly, we found that the vast majority are induced
during myogenesis, and belong to cluster 1 (highly
induced, 112 genes) or cluster 2 (moderately induced, 48
genes), in the differentiation time course expression
proﬁles shown in Figure 3A. Interestingly, the
knock-down of SIX4 also caused the down-regulation of
several of these SIX1 target genes (Supplementary
Table S5), further reinforcing the notion that SIX1 and
SIX4 may exert their functions at least partially together.
Gene expression information after the knock-down of
MYOG allows us to discern two categories of SIX1
targets: those that also depend on MYOG function for
efﬁcient induction during differentiation, and the
MYOG-independent SIX1 targets, which are unaffected
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Nucleic Acids Research, 2010,Vol.38, No. 20 6863by the suppression of this MRF. MYOG-dependent
targets therefore reﬂect the requirement of these genes
for both SIX and MYOG in the induction process. In
addition to demonstrating an essential regulatory role
for SIX1 and SIX4 in enabling gene expression induction
and differentiation of myoblasts, these results provide
further support to the notion of cooperation between the
MRF and SIX classes of transcriptional regulators.
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Having identiﬁed a group of genes depending on SIX1,
SIX4 and MYOG expression for appropriate induction
during differentiation, we ﬁnally set out to determine if
these TFs can regulate gene expression in a cooperative
manner. For this, we used luciferase assays where reporter
constructs contained tandem copies of the MEF3 or the
E-box elements, or both types of elements together,
upstream of a TATA box and the ﬁreﬂy luciferase gene.
These constructs were co-transfected in 293T cells along
with various combinations of expression plasmids for
SIX1, SIX4, and MYOD or MYOG together with the
E-protein HEB-b. This cell line was chosen for its lack
of expression of the MRFs, giving lower background
signal in these assays. We found that SIX4, but not
SIX1, activates constructs containing MEF3 sites
(Figure 4A). This is perhaps due to the facts that SIX1
requires additional co-activators to be present which
might be in limiting amounts (38), or that it functions in
certain contexts as a repressor (39). Both MYOD and
MYOG activated transcription from the E-box-containing
constructs. Interestingly, there was a signiﬁcant and
strong, well above additive effect of combined SIX4 and
MYOD or MYOG, indicating that the two classes of TFs
indeed have the ability to synergize in regulating gene ex-
pression. The extent of synergy is 5.43 for SIX4 and
MYOD, and 5.06 for SIX4 and MYOG. We note that
the effect of MYOD and MYOG are stronger on the con-
struct containing both MEF3 and E-box elements,
perhaps due to the fact that 293T cells express certain
members of the SIX family, including SIX4 (data not
shown). The synergy between SIX4 and the MRFs
depends on the presence of both cognate binding sites;
therefore it is unlikely that it relies only on protein–
protein interactions. This fact also rules out the possibility
that the abundance of one TF impacts transcription indir-
ectly, for example by enhancing the expression of the other
factor.
In order to further validate the speciﬁcity of this tran-
scriptional synergy, we generated reporter constructs con-
taining multiple copies of the E2F binding site, alone or
with tandem copies of the MEF3 or E-box sequence
elements (Figure 4B). E2F sites are bound by the
E2F1-DP1 pair, which is involved in regulating progres-
sion through the cell cycle (40). No signiﬁcant transcrip-
tional cooperation was observed between E2F1-DP1 and
either SIX4 or the MRFs. This supports the idea that the
synergy between SIX4 and the MRFs is speciﬁc to these
two classes of transcriptional activators, and that it does
not reﬂect a general propensity for these factors to cooper-
ate with other regulators indiscriminately.
We also veriﬁed that transcriptional synergy between
the MRFs and SIX factors can occur in myoblasts, in
addition to 293T cells. We therefore repeated these
luciferase reporter assays in C2C12 cells, and found that
indeed SIX4 can cooperate with MYOD or MYOG to
activate transcription in this setting (Figure 4C).
Finally, because the myogenin gene promoter has been
shown to be under the control of MYOD (41) and Six
factors (23) during development, we asked whether
members of each family could synergize together. SIX4
and MYOD activated the reporter gene luciferase fused
to the myogenin promoter in a synergistic fashion
(Figure 4D). The synergy depends entirely on the
presence of a MEF3 site since it is completely abrogated
when a reporter construct with a mutation in the MEF3
site is used. Here again, the MEF3 site requirement rules
out the possibility that the synergy merely relies on
protein–protein interactions between SIX factors and the
MRFs. To conclude, we analyzed the luciferase activity
from the wild-type or MEF3-mutated myogenin reporter
construct, in C2C12 cells that are undergoing differenti-
ation. As expected, luciferase activity is much higher in
MT than in myoblasts, when the wild-type construct is
compared with the empty reporter plasmid pGL3-Basic
(Figure 4E). When a mutation is introduced in the
MEF3 site, this induction is strikingly reduced by 70%,
as compared to the wild-type construct. These results
strongly suggest that cooperation between SIX and
MRF factors is required for proper induction of the ex-
pression of target genes such as myogenin.
Together, our data indicate a likely mechanism by
which the transcriptional function of MRFs may be
modulated during myogenesis, that is by cooperation
with SIX TFs.
DISCUSSION
The work presented here provides evidence that MRFs
and SIX family TFs function in a cooperative manner to
regulate gene expression during skeletal myogenesis.
Additionally, the data contained herein offers interesting
insight to the question of the molecular basis of the devel-
opmental defects in Six1-null animals.
Gene transcription is rarely regulated by single TFs in
isolation, and combinatorial regulation offers a means by
which precise expression proﬁles can be established. This
occurs when the combined action of two transcriptional
regulators together generates a transcriptional output that
is different from that obtained with either factor alone.
The timing, amplitude or duration of the transcriptional
response, or the selection of target sites, may be
modulated in a combinatorial manner (42). These consid-
erations are often discussed in theoretical terms, and while
the scientiﬁc literature abounds with tools to predict
instances of combinatorial regulation [e.g. (43,44)], much
fewer studies have gone beyond reporting the
co-occurrence of TF binding sites. The work presented
herein represents a step further in explaining ﬁne-tuning
of gene expression within the transcriptional regulatory
network that oversees myogenesis.
Using bioinformatic analysis of DNA sequences, we
have uncovered a novel way by which MRF function
might be modulated, that is by cooperation with SIX
family TFs. In our previous work, a high abundance of
MEF3 sites, the DNA sequence recognized by SIX
factors, was found at MRF target genes most induced
during differentiation, but not at MRF targets with
modest or no induction (9). Conversely, our current
ﬁndings demonstrate the speciﬁc enrichment of the
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Figure 4. Transcriptional synergism between SIX and MRF transcription factors. (A) 293T cells were transfected with the indicated ﬁreﬂy luciferase
reporter constructs and various combinations of expression plasmids for transcription factors, as indicated. A plasmid driving the expression of
renilla luciferase was used as internal control, for normalization purposes. Normalized ﬁreﬂy luciferase activities were divided by those obtainedi n
cells transfected with the empty expression plasmid, giving values of fold activation over empty plasmid. Each experiment was performed a minimum
of three times. Histogram values represent the average±SEM of all replicates. Note the axis break and change of scale. For conditions with a
combination of transcriptional activators, the synergy value is indicated above the histogram bar. Synergy values that are statistically signiﬁcant
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Moreover, our ChIP-on-chip and expression proﬁling ex-
periments conﬁrmed that the function of SIX and MRF
factors are in several cases tightly connected: we un-
covered a substantial group of direct SIX1 target genes
which are also direct targets of MYOD or MYOG
(9–11). This novel notion of cooperation between SIX
and MRFs is reinforced by the results of our promoter
reporter assays: the two families of TFs activate transcrip-
tion in a synergistic fashion. Our data suggest that the
function of SIX factors in combinatorial regulation with
the MRFs would be to allow maximum target gene acti-
vation by these myogenic regulators. Our ﬁndings evoke a
model (Figure 5) whereby SIX1 function is not only
upstream of the MRFs, during embryonic development,
but also parallel to them, during terminal differentiation
of myoblasts. At the same time, SIX factors also function
independently of MRF activity to induce during myogenic
differentiation the expression of a distinct set of target
genes, possibly in concert with different TFs.
The exact mechanism by which the synergy between
SIX4 and the MRFs is made possible is not perfectly
clear at this stage. Logically, one would expect the two
classes of TFs to enhance distinct steps of the transcrip-
tion process, such as initiation, elongation, or the estab-
lishment of a permissive chromatin structure at the
proximal promoter (45). The MRFs are able to recruit
certain transcriptional co-activators to target promoters.
For instance, MYOD can recruit the PCAF histone
acetyltransferase, via an interaction with P300, which
enhances its transcriptional activity (46,47). It can also
interact with TAF3 (TATA-binding protein Associated
Factor 3), thereby enhancing activation of target genes
(48). MYOG can interact with RBP3, a core subunit of
the RNA polymerase II complex (49), an interaction
which is also thought to facilitate target gene transcrip-
tion. SIX factors, on the other hand, are best characterized
with regards to their interactions with the EYA and
DACH families of transcriptional co-regulators (50).
How EYA co-factors enhance RNA pol II-dependent
transcription is currently unclear, but is thought to
involve their enzymatic activity as protein phosphatases,
and they may act at least partly by reversing the repressive
effect of DACH proteins on SIX function (16). This is
thought to involve the CREB-binding protein CBP, a
protein related to P300 (51). Combinatorial regulation of
transcription may in certain instances involve interaction
between cooperating TFs. However, we believe this not to
be the case with SIX and MRF proteins. In numerous
attempts, we have failed to detect an interaction between
members of these two families, in co-immunoprecipitation
assays. Furthermore, our results with luciferase reporter
assays clearly indicate that cooperative function of the two
families of TFs requires the binding of each factor to their
respective binding site. Even if direct contacts between
these proteins are made, they are unlikely to be sufﬁcient
for synergy to occur. Finally, two recent reports shed light
on possible mechanisms by which SIX factors could
regulate target gene expression and potentiate the
function of MRFs. A recent report demonstrates that re-
cruitment of SIX4 and the histone demethylase UTX at
the Myog and Ckm (muscle creatine kinase) promoters is
required for induction of these genes at the onset of
myoblast differentiation (52). UTX functions by
removing methyl groups from histone H3 lysine 27, a
covalent chromatin mark which is associated with tran-
scriptional repression (53). A second recent study has
shown that the myogenin locus, which depends on
MRFs and SIX factors for proper expression, is
methylated on DNA in undifferentiated cells, and that
loss of CpG methylation coincides with its activation;
this removal or loss of DNA methylation depends on
SIX1 function (54). These two studies therefore reveal
the possibility that SIX factors recruit enzymes, or
enzyme complexes, which render the chromatin template
more conducive to transcription and to MRF function,
explaining synergistic function. Another non-mutually ex-
clusive scenario is that binding of MRFs to their target
loci is facilitated by the chromatin reorganization
mediated by SIX factors. More work will be required to
elucidate the mechanistic details of these possibilities and
to determine if these phenomena are widespread or limited
to only a subgroup of SIX and MRF target loci.
Our luciferase assays demonstrated a strong activity of
SIX4, but not SIX1, as transcriptional activator on the
constructs tested. It is possible that levels of transcription-
al co-regulators required to interact with over-expressed
SIX1 in order for an activation response to be generated
are suboptimal in the system we used. Both cell lines used
in luciferase assays (C2C12 and 293T) endogenously
express SIX1 and SIX4, but endogenous SIX4 may be
the only one in limiting amounts. It is also possible that
SIX1 is required for SIX4 transcriptional function, and
that the synergy with the MRFs requires the transcription-
al activation domain of SIX4 [the SIX1 protein lacking a
similar domain (12)]. This would not be an isolated case,
since the cooperative function between SIX4 or SIX5 and
their EYA co-factors indeed requires these C-terminal ac-
tivation domains (55). In further support of the notion
that the functions of SIX1 and SIX4 are tied together
are the following three facts: (i) a marked number of
SIX1 targets we tested in gene-speciﬁc qChIP assays also
Figure 4. Continued
(P<0.05 by one-tailed paired t-test) are marked in red with an asterisk. (B) The experiment was performed as in panel A, but using different
combinations of reporter constructs and transcriptional activators. Synergy is indicated as in panel A. (C) Transcriptional activity of SIX factors and
the MRFs in C2C12 myoblasts. Cells were transfected with the indicated ﬁreﬂy luciferase reporter constructs and various combinations of expression
plasmids for transcription factors, as indicated. Samples and data were processed as in panel A. (D) Transcriptional activity of SIX4 and MYOD in
293T cells transfected with a reporter construct consisting of the myogenin proximal promoter fused to the luciferase gene, or with a similar construct
where the MEF3 site has been mutated. Samples and data were processed as in panel A. (E) Luciferase activity in cells transfected with the wild-type
myogenin promoter reporter construct or a version with its MEF3 site mutated, or the empty luciferase plasmid (pGL3-basic). The results show the
ratio of luciferase activity in MT divided by that in myoblasts.
Nucleic Acids Research, 2010,Vol.38, No. 20 6867proved to be bound by SIX4, (ii) our knock-down experi-
ments indicate that a very substantial number of these
SIX1/SIX4 targets depend on wild-type levels of both
proteins for their induction during differentiation and
(iii) terminal differentiation is greatly lowered upon
SIX4 or SIX1 knock-down. This is not due to decreased
SIX1 expression after SIX4 knock-down, since in fact Six1
mRNA levels are slightly but signiﬁcantly higher after
SIX4 knock-down (Supplementary Figure S4).
A clear requirement for SIX1 during embryonic muscle
development has been established before (14–16).
However, the molecular basis of the developmental
defects in Six1-null animals remains to be ﬁrmly estab-
lished. Using ChIP-on-chip, we have identiﬁed a large
number of new direct target genes of the SIX1 TF,
which signiﬁcantly extend its previously known target rep-
ertoire. Interestingly, we have discovered binding sites for
SIX1 in the vicinity of genes that play critical roles in
skeletal myogenesis, and which have been shown to be
deregulated in SIX1 knock-out embryos. For example,
the Pax3, Myf5, Myod1, Myog and Pbx1 gene were
found to represent direct SIX1 and SIX4 targets. The rele-
vance of binding of these genes by SIX factors in C2C12
myoblasts, which do not express certain of these target
genes at any detectable level, and in the developing em-
bryonic muscle, where a clear requirement for these genes
has been established, deserves further scrutiny.
A related observation we made is that numerous SIX1
targets identiﬁed herein are well known to control the
function or development of other tissues affected by the
loss of SIX1 in mice. For instance, SIX1 is essential for
the development of various sensory tissues, such as the
otic and olfactory epithelia, as well as the kidney, and
we found SIX1 to bind several genes involved in these
processes (e.g. Gdnf, Bdnf, Pbx1, Spry1, Grm1, Mef2c,
Hes6) (56–61). It is certainly a surprise to ﬁnd SIX1
binding to such genes in a myoblast cell line, which is
presumably restricted to a mostly myogenic fate. It will
be interesting to determine whether these genes also par-
ticipate in muscle development and/or function, and if
their deregulation in Six1-null animals contributes to the
muscle phenotype, since most of these genes are in fact
expressed, and therefore potentially functional, in
myoblasts. Mef2c and Hes6 are two examples of develop-
mental regulators which deﬁnitely support this hypothesis,
as they are involved in both neuronal and muscular
processes (62–66), and their expression in differentiating
myoblasts depends on SIX factors (Supplementary Table
S6 and Supplementary Figure S5). Likewise, Pbx1 is a
gene involved in both myogenesis and nephrogenesis
(67,68) and could work downstream of SIX1 in both
muscle and kidneys.
Using RNA interference of SIX factors, we discovered
that SIX4 is essential to terminal differentiation of
myoblasts. This reinforces the notion that the synergistic
function SIX4 carries out with the MRFs is crucial for
myogenesis. However, this observation is seemingly at
odds with the absence of a clear muscle phenotype in
Six4 knock-out mice (17). We suggest that the compensa-
tory mechanisms which mask the effects of loss of SIX4
expression during embryonic development do not function
in our myoblast culture model. SIX5 is the only other SIX
family member with an extended C-terminal activation
domain similar to that of SIX4. It has been hypothesized
Six1 Six4
Myog/
Myod
Six- and MRF-dependent genes
.  .  .
Myh8
Ldb3
Tead4
Tnnt3
Ankrd2
Targets unique to Six Targets unique to Myod/Myog
Figure 5. Model of SIX and MRF function during myoblast differentiation. See text for details.
6868 Nucleic Acids Research, 2010,Vol.38, No. 20that SIX5 levels in embryonic myogenic structures are suf-
ﬁciently high to compensate for the absence of SIX4
(17,69). In contrast, SIX5 is expressed at only very low
levels in C2C12 cells (Supplementary Figure S5), and its
levels are unaffected by SIX1 or SIX4 knock-down
(Supplementary Table S4). Therefore, it may not
function in a compensatory manner as it does in the
embryo. Moreover, the time scales of events in these two
loss-of-function systems (RNA interference in cultured
cells, compared with developing knock-out embryo) are
different, which may also explain differences in the emer-
gence of compensatory responses, or lack thereof. Finally,
this SIX4 ablation phenotype speciﬁc to adult myoblasts
suggests that SIX4 function may be required primarily for
myogenic regeneration. In this context, it will be of par-
ticular interest to study the impact of conditional loss of
function of SIX factors during the repair of adult muscle
tissue.
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